Genetic distribution in Chinese patients with hereditary peripheral neuropathy.
- Author:
Xiao Xuan LIU
1
;
Xiao Hui DUAN
2
;
Shuo ZHANG
1
;
A Ping SUN
1
;
Ying Shuang ZHANG
1
;
Dong Sheng FAN
1
Author Information
1. Department of Neurology, Peking University Third Hospital, Beijing 100191, China.
2. Department of Neurology, China-Japan Friendship Hospital, Beijing 100029, China.
- Publication Type:Journal Article
- Keywords:
China;
Genes;
Hereditary sensory and motor neuropathy
- MeSH:
Amyotrophic Lateral Sclerosis;
Charcot-Marie-Tooth Disease/genetics*;
DNA Helicases/genetics*;
DNA-Binding Proteins/genetics*;
Flavoproteins;
HSP40 Heat-Shock Proteins;
Humans;
Intracellular Signaling Peptides and Proteins/genetics*;
Kinesins;
Ligases/genetics*;
Molecular Chaperones;
Multifunctional Enzymes;
Muscular Atrophy, Spinal/genetics*;
Mutation;
Phosphoric Monoester Hydrolases;
Protein Serine-Threonine Kinases;
RNA Helicases/genetics*;
RNA, Transfer;
Transcription Factors/genetics*
- From:
Journal of Peking University(Health Sciences)
2022;54(5):874-883
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the distribution characteristics of hereditary peripheral neuropathy (HPN) pathogenic genes in Chinese Han population, and to explore the potential pathogenesis and treatment prospects of HPN and related diseases.
METHODS:Six hundred and fifty-six index patients with HPN were enrolled in Peking University Third Hospital and China-Japan Friendship Hospital from January 2007 to May 2022. The PMP22 duplication and deletion mutations were screened and validated by multiplex ligation probe amplification technique. The next-generation sequencing gene panel or whole exome sequencing was used, and the suspected genes were validated by Sanger sequencing.
RESULTS:Charcot-Marie-Tooth (CMT) accounted for 74.3% (495/666) of the patients with HPN, of whom 69.1% (342/495) were genetically confirmed. The most common genes of CMT were PMP22 duplication, MFN2 and GJB1 mutations, which accounted for 71.3% (244/342) of the patients with genetically confirmed CMT. Hereditary motor neuropathy (HMN) accounted for 16.1% (107/666) of HPN, and 43% (46/107) of HPN was genetically confirmed. The most common genes of HMN were HSPB1, aminoacyl tRNA synthetases and SORD mutations, which accounted for 56.5% (26/46) of the patients with genetically confirmed HMN. Most genes associated with HMN could cause different phenotypes. HMN and CMT shared many genes (e.g. HSPB1, GARS, IGHMBP2). Some genes associated with dHMN-plus shared genes associated with amyotrophic lateral sclerosis (KIF5A, FIG4, DCTN1, SETX, VRK1), hereditary spastic paraplegia (KIF5A, ZFYVE26, BSCL2) and spinal muscular atrophy (MORC2, IGHMBP, DNAJB2), suggesting that HMN was a continuum rather than a distinct entity. Hereditary sensor and autosomal neuropathy (HSAN) accounted for a small proportion of 2.6% (17/666) in HPN. The most common pathogenic gene was SPTLC1 mutation. TTR was the main gene causing hereditary amyloid peripheral neuropathy. The most common types of gene mutations were p.A117S and p.V50M. The symptoms were characterized by late-onset and prominent autonomic nerve involvement.
CONCLUSION:CMT and HMN are the most common diseases of HPN. There is a large overlap between HMN and motor-CMT2 pathogenic genes, and some HMN pathogenic genes overlap with amyotrophic lateral sclerosis, hereditary spastic hemiplegia and spinal muscular atrophy, suggesting that there may be a potential common pathogenic pathway between different diseases.
